Table 1.
Baseline characteristics and clinical data at the two study groups
| Variation |
GnRH agonist
(n = 60) |
No GnRH agonist
(n = 40) |
P value |
|---|---|---|---|
| Total numbers of cycles | 60 | 40 | |
| Total numbers of ET | 60 | 38 | |
| Cancelled cycles | 0 | 2 | |
| Age, years | 30 ± 5.1 | 32 ± 5.9 | 0.065 |
| Duration of infertility, years | 8.9 ± 5.1 | 9.8 ± 5.6 | 0.429 |
| Body mass index, kg/m2 | 26.5 ± 4.3 | 27.3 ± 3.3 | 0.308 |
| Type of infertility | |||
| Primary | 45 (76.3) | 31 (79.0) | 0.712 |
| Secondary | 14 (24.0) | 8 (21.0) | 0.724 |
| Endometrial thickness (mm) | 10 ± 1.7 | 10.7 ± 2.9 | 0.229 |
| Number of embryos transferred | 136 | 98 | 0.516 |
| Number of embryos transferred/ET | 2.2 | 2.5 | 0.805 |
ET = embryo transfer
Results are presented as mean ± SD or number (%)